Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 30, 2023

Claims for Patent: 9,050,309

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

Summary for Patent: 9,050,309

Title:	DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
Abstract:	DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form, therapeutic methods for their use, and processes for refining the compositions from fish oil are presented.
Inventor(s):	Maines; Timothy J. (Potomac, MD), Machielse; Bernardus N M (North Potomac, MD), Mehta; Bharat M. (Mendham, NJ), Wisler; Gerald L. (Windermere, FL), Davidson; Michael H. (Highland Park, IL), Wood; Peter Ralph (Cotherstone, GB)
Assignee:	Omthera Pharmaceuticals, Inc. (Princeton, NJ) Chrysalis Pharma AG (Sacheln, CH)
Application Number:	13/797,557
Patent Claims:	1. A pharmaceutical composition, comprising: EPA, in a weight percent amount of 50% to 60%; DHA, in a weight percent amount of 17% to 23%; DPA, in a weight percent amount of 1% to 8%; wherein at least 90% by weight of the polyunsaturated fatty acid in the composition is present in the free acid form. 2. The pharmaceutical composition of claim 1, wherein at least 95% by weight of the polyunsaturated fatty acid in the composition is present in the free acid form. 3. The pharmaceutical composition of claim 1, wherein DPA is present in a weight percent amount of at least 1.5%. 4. The pharmaceutical composition of claim 3, wherein DPA is present in a weight percent amount of at least 2%. 5. The pharmaceutical composition of claim 4, wherein DPA is present in a weight percent amount of at least 2.5%. 6. The pharmaceutical composition of claim 5, wherein DPA is present in a weight percent amount of at least 3%. 7. The pharmaceutical composition of claim 6, wherein DPA is present in a weight percent amount of at least 3.5%. 8. The pharmaceutical composition of claim 7, wherein DPA is present in a weight percent amount of at least 4%. 9. The pharmaceutical composition of claim 8, wherein DPA is present in a weight percent amount of at least 4.5%. 10. The pharmaceutical composition of claim 1, wherein the composition comprises a unit dose of at least 500 mg of the composition. 11. The pharmaceutical composition of claim 1, wherein the composition comprises a unit dose of about 1 gram of the composition.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Colorcon

Harvard Business School

Johnson and Johnson

McKinsey

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.